Crossmark

Cardiovascular and prostate cancer risk associated to testosterone replacement therapy – a systematic review and meta-analysis of 41 randomized controlled trials

Crossref DOI link: https://doi.org/10.1038/s41443-026-01237-4

Published Online: 2026-02-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

García-Becerra, Carlos A. https://orcid.org/0000-0003-2838-6251
Arias-Gallardo, Maria I. https://orcid.org/0009-0000-4433-5345
Juárez-García, Jesús E. https://orcid.org/0009-0000-5027-7540
Soltero-Molinar, Verónica

Parra-Camaño, Luis F.

Rivera-Rocha, Mariabelen I.

García-Becerra, Natalia

García-Gutiérrez, Carlos M.
License Information

Text and Data Mining valid from 2026-02-11

Version of Record valid from 2026-02-11
More Information

Article History

Received: 20 May 2025

Revised: 5 January 2026

Accepted: 31 January 2026

First Online: 11 February 2026

Competing interests

: In compliance with ethical standards, authors declare that there is not a single conflict of interest to declare.

Document is current

Any future updates will be listed below